Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease.
about
Local amplification of glucocorticoids in the aging brain and impaired spatial memoryChronic Stress-induced Hippocampal Vulnerability: The Glucocorticoid Vulnerability HypothesisThe myth of schizophrenia as a progressive brain diseaseAntiglucocorticoid and related treatments for psychosisAntiglucocorticoid and related treatments for psychosisThe role of the hippocampus in the pathophysiology of major depressionBrain on stress: how the social environment gets under the skinCaffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levelsHospitalization and cognitive decline: Can the nature of the relationship be deciphered?Comorbidities in Cushing's diseaseThe brain on stress: Insight from studies using the Visible Burrow SystemThe dynamics of the stress neuromatrixHippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposureChronic stress and brain plasticity: Mechanisms underlying adaptive and maladaptive changes and implications for stress-related CNS disordersPosttraumatic stress disorder and the nature of traumaStress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine.A single high dose of dexamethasone affects the phosphorylation state of glutamate AMPA receptors in the human limbic systemMR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders.Imaging stress effects on memory: a review of neuroimaging studies.Central nervous system effects of natural and synthetic glucocorticoids.Implications of adult hippocampal neurogenesis in antidepressant action.Promising Links between Meditation and Reduced (Brain) Aging: An Attempt to Bridge Some Gaps between the Alleged Fountain of Youth and the Youth of the Field.Widespread reductions of white matter integrity in patients with long-term remission of Cushing's diseaseDepression and Anxiety Scores Are Associated with Amygdala Volume in Cushing's Syndrome: Preliminary Study.Mice overexpressing corticotropin-releasing factor show brain atrophy and motor dysfunctions.Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease.The Douglas Hospital Longitudinal Study of Normal and Pathological Aging: summary of findings.Neuroplasticity and cellular resilience in mood disorders.Postprandial plasma PYY concentrations are associated with increased regional gray matter volume and rCBF declines in caudate nuclei--a combined MRI and H2(15)O PET study.Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling.Stress controversies: post-traumatic stress disorder, hippocampal volume, gastroduodenal ulceration*.Effects of lamotrigine on hippocampal activation in corticosteroid-treated patients.Are glucocortoids responsible for putative hippocampal damage in PTSD? How and when to decide.Atrophy of the hippocampus in posttraumatic stress disorder: how and when?Chronic stress enhances ibotenic acid-induced damage selectively within the hippocampal CA3 region of male, but not female ratsGlucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder.Action of glucocorticoids on survival of nerve cells: promoting neurodegeneration or neuroprotection?Of mice and men: modelling post-stroke depression experimentally.Substantial and reversible brain gray matter reduction but no acute brain lesions in ultramarathon runners: experience from the TransEurope-FootRace Project.The therapeutic value of yoga in neurological disorders
P2860
Q21558420-4A499C9A-16DE-4C92-A19A-1FC5D5CF558BQ21651040-7B40F748-9884-420F-831D-94309474404BQ24067152-FAF12CFA-06A9-4F37-A609-1EDEB4AEB47DQ24186594-45EDACF3-9BD5-4989-BC03-1DD929495527Q24243495-D0EA8017-8535-486B-9A4C-E4041CB4C39EQ24561923-E5EA91CA-C59F-4755-937E-C7676ACB1D82Q24626878-D895E2A1-3DFD-4041-B7C3-CFDFBA7E123DQ24642453-C0B869D5-E36B-45EE-8246-E75972783833Q26851206-AE86BBDB-5F04-4FD6-8B64-11088EDBFA84Q27010491-20B93643-F6BD-4123-8CAB-E5F2B34B480EQ27027958-3B572B1B-F902-4083-A7DB-4D1E9B187956Q28076408-5A05B649-AE45-437C-9322-494E0681E1D4Q28346146-0AFBC08A-66B0-469B-A835-45FBCCF58866Q30371216-BBD67A9C-D8FD-4036-BC94-35484FD9CDD1Q30473433-3C521D1E-01FA-4A3B-B5FD-BB296C33D0E3Q30531104-8ED7C53F-9EC9-4F8B-83E2-ECDCF18B2FEDQ30837357-BEB73046-8AAD-457F-ACCD-28F5BB820440Q30957247-FABE73ED-3FDB-4F62-9583-721B59E54158Q33403671-0755A76F-3BEF-4CCB-9BB8-7B67FDBF3A85Q33507425-D7715D18-7174-4F59-BE50-D14300835BBBQ33553686-90500005-2821-4937-8AEC-15DB88931A77Q33736599-1A00EAD1-AC8B-44A7-9BCF-7477EB3FCDA1Q33741321-C75F6111-DD94-4BCD-A7E7-47CEE3951215Q33747974-02C9E256-915F-47C3-9843-B0A57BF37E71Q33767416-EF77307A-E8FD-4EBC-AD0A-32D2285BC956Q33829618-14302670-496D-4633-88BA-D63237A4C50BQ33939771-81CCD5A0-0065-4DEF-9B01-6C3C9D25DCC0Q34111006-E251DE70-F17B-4B74-A88E-0B9D7D51BEC9Q34125438-6155E8D4-68B1-416E-88D2-3BABB97EC125Q34137906-F3F03B3F-A460-40BF-B91D-EB93304E3FD5Q34145538-649E5635-7DD3-4A68-9226-631062DFCFDFQ34163889-7ABC0A04-01C2-49BF-B645-E58647F0F380Q34246665-36588DAF-2564-40CF-9050-7F5E96C4323DQ34246673-6D1F2F0C-A4C4-42EA-9EE7-67D1FE148733Q34335399-EB4B0993-2537-4412-BD8D-A12440707C0DQ34343734-23E27BC6-F38F-4DD7-A766-530A6967AC1EQ34385964-515D8EAE-CB2E-47CE-A771-631CD63E0298Q34407158-46ACD959-CD21-48DD-AE4C-F18EF4FE05D0Q34520058-D7B52DAC-9876-4A97-8097-97704D1A457DQ34561855-35B0B225-1E7C-4B36-96B8-243853A11CBC
P2860
Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Decrease in cortisol reverses ...... reatment of Cushing's disease.
@ast
Decrease in cortisol reverses ...... reatment of Cushing's disease.
@en
type
label
Decrease in cortisol reverses ...... reatment of Cushing's disease.
@ast
Decrease in cortisol reverses ...... reatment of Cushing's disease.
@en
prefLabel
Decrease in cortisol reverses ...... reatment of Cushing's disease.
@ast
Decrease in cortisol reverses ...... reatment of Cushing's disease.
@en
P2093
P1476
Decrease in cortisol reverses ...... reatment of Cushing's disease.
@en
P2093
Gebarski SS
Giordani B
Schteingart DE
Starkman MN
P304
P356
10.1016/S0006-3223(99)00203-6
P407
P577
1999-12-01T00:00:00Z